Cost-effectiveness of allopurinol versus febuxostat in the treatment of gout patients: A systematic review

Background: In recent years, increased longevity, poor dietary habits, and the rising prevalence of metabolic syndrome and hypertension have increased the prevalence of gout. Gout significantly increases direct and indirect costs and reduces the quality of life. Allopurinol and febuxostat are the mo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Med J Islam Repub Iran
Main Authors: Rezapour, Aziz, Alidoost, Saeide, Asgharzadeh, Asra, Farhadi, Zeynab, Khodadadi, Najme, Mohammadi Bakhsh, Roghayeh, Sepehrian, Razieh, Salemi, Morteza, Taheri Mirghaed, Masood, Behzadifar, Masoud, Sohrabi, Rahim
Formato: Artigo
Idioma:Inglês
Publicado em: Iran University of Medical Sciences 2020
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7456432/
https://ncbi.nlm.nih.gov/pubmed/32884916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.34171/mjiri.34.41
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados